ZNF503-AS2: A Potential Drug Target and Biomarker (G100131213)
ZNF503-AS2: A Potential Drug Target and Biomarker
Zinc finger nucleosome (ZFN) proteins are a family of non-coding RNAs that play a crucial role in various cellular processes. One of the ZFN proteins, ZNF503-AS2, has been identified as a potential drug target and biomarker. In this article, we will discuss the ZNF503-AS2 protein, its functions, potential drug targets, and potential use as a biomarker.
ZNF503-AS2: A Zinc Finger Nucleosome Protein
ZNF503-AS2 is a 21 kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is a member of the ZNF family, which includes other well-known proteins such as ZNF2, ZNF4, and ZNF5. ZNF503-AS2 is characterized by the presence of a zinc finger domain, which is a common feature of many ZFN proteins.
Function and Interactions
ZNF503-AS2 is involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It plays a role in regulating the expression of other genes by binding to their DNA binding sites. ZNF503-AS2 has been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3.
Potential Drug Target
ZNF503-AS2 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the potential drug targets for ZNF503-AS2 is its role in cell apoptosis. ZNF503-AS2 has been shown to be involved in the regulation of cell apoptosis, which is a critical process that helps the body remove damaged or dysfunctional cells.
In addition to its role in apoptosis, ZNF503-AS2 has also been shown to be involved in cell proliferation. It has been shown to play a positive role in the regulation of cell proliferation and has been shown to promote the growth of various types of cancer cells.
ZNF503-AS2 has also been identified as a potential biomarker for various diseases, including cancer. Its involvement in the regulation of cellular processes makes it a promising biomarker for various types of cancer, including neuro cancer, breast cancer, and lung cancer.
ZNF503-AS2 is a unique protein that has been identified as a potential drug target and biomarker. Its role in cell apoptosis and its involvement in the regulation of cell proliferation make it a promising target for drug development. Additionally, its potential use as a biomarker for various types of cancer makes it an important addition to the toolkit for cancer researchers.
Protein Name: ZNF503 Antisense RNA 2
More Common Targets
ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610